Withdrawal

The Education of Dispensary Staff is Varied and Lacks Regulation

Training and Practices of Cannabis Dispensary Staff

How much medical training does your local budtender possess? An online survey sent to medical marijuana dispensary staff reported only 55% of staffers had any formal training for their position, with 20% reporting some background in medical/scientific training. The analysis reported that many among the dispensary staff are recommending cannabis choices that are consistent with current evidence, but some are recommending strains that are either ineffective or exacerbate a patient’s condition. The findings of this study stress the importance of consistent and well-regulated training of dispensary staff.

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/2FfJNSC     inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDThe Education of Dispensary Staff is Varied and Lacks Regulation
read more

A 2018 study finds that cannabis can alleviate symptoms of medications used for chronic pain as well as serve as an alternative treatment for seizures, pain, and inflammation.

Benjamin Caplan, MDA 2018 study finds that cannabis can alleviate symptoms of medications used for chronic pain as well as serve as an alternative treatment for seizures, pain, and inflammation.
read more

Guanfacine reducing cannabis withdrawal symptoms?

Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers

A study performed on daily cannabis users with cannabis use disorder (CUD) found evidence for Guanfacine to reduce the irritability and disturbances to sleep, characteristic of cannabis withdrawal. It is potentially a viable, improved alternative to Lofexidine, another treatment for CUD which happens to result in some adverse effects, including drowsiness, dizziness, and altered food intake. However, beyond these effects, while Lofexidine reduced cannabis self-administration following abstinence, Guanfacine did not in this study. Regardless, further research on the therapeutic effects of Guanfacine may be worthwhile and could help reduce cannabis cravings following withdrawal.

For the full review & to explore related work:

This paper is also stored here: http://bit.ly/2wsKbZh inside the CED Foundation Archive

Benjamin Caplan, MDGuanfacine reducing cannabis withdrawal symptoms?
read more

Combatting Cannabis Withdrawal Syndrome

DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults

Cannabis withdrawal syndrome affects approximately 12.1% of heavy cannabis users and is characterized by symptoms such as nervousness/anxiety, hostility, sleep difficulty, and depressed mood. It has increased prevalence among those suffering from mood disorders, anxiety disorders, and personality disorders. This new data should emphasize the need for physicians to exercise caution when recommending cannabis to individuals who may end up consuming cannabis heavily, and who also suffering from mood, anxiety, or personality disorders

http://bit.ly/2XeL7wl

Benjamin Caplan, MDCombatting Cannabis Withdrawal Syndrome
read more